#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA630397	A	Mouse plasma levels are obtained 24 hr after oral administration of 100 mg/kg of compound.	Mus musculus	8	ALA1132549	organism-based format	Scientific Literature
2.	ALA630398	A	Mouse plasma levels are obtained 6 hr after oral administration of 100 mg/kg of compound.	Mus musculus	9	ALA1132549	organism-based format	Scientific Literature
3.	ALA678320	B	FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro.		33	ALA1132549	single protein format	Scientific Literature
4.	ALA800094	F	Percent inhibition of VEGF-mediated estradiol benzoate-induced rat uterus weight gain at 60 mg/kg oral dose	Rattus norvegicus	1	ALA1132549	organism-based format	Scientific Literature
5.	ALA811931	B	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.		35	ALA1132549	single protein format	Scientific Literature
6.	ALA812620	B	Vascular endothelial growth factor receptor 2 inhibitory activity at 2 uM of ATP in vitro.		33	ALA1132549	single protein format	Scientific Literature
7.	ALA852072	B	Ratio of IC50 of FGFR-1 (FTK) to VEGFR-1 (Flt).		28	ALA1132549	assay format	Scientific Literature
8.	ALA852073	B	Ratio of IC50 of FGFR-1 (FTK) to VEGFR-2 (KDR).		29	ALA1132549	protein format	Scientific Literature
9.	ALA3301364	P	ASTRAZENECA: Solubility in pH7.4 buffer using solid starting material using the method described in J. Assoc. Lab. Autom. 2011, 16, 276-284. Experimental range 0.10 to 1500 uM		1,763	ALA3301361	small-molecule physicochemical format	AstraZeneca Deposited Data
10.	ALA3778237	B	Inhibition of human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	Homo sapiens	44	ALA3774350	assay format	Scientific Literature
11.	ALA3778238	B	Inhibition of recombinant His-tagged human KDR expressed in insect Sf21 cells preincubated for 15 mins followed by substrate addition measured after 20 mins by HTRF assay	Homo sapiens	44	ALA3774350	cell-based format	Scientific Literature
12.	ALA3778239	B	Selectivity ratio of IC50 for recombinant His-tagged human KDR expressed in insect Sf21 cells to IC50 for human RET cytoplasmic domain (658 to 1114 residues) expressed in baculovirus system	Homo sapiens	44	ALA3774350	cell-based format	Scientific Literature
13.	ALA3778240	B	Inhibition of KIF5B/RET (unknown origin) expressed in mouse BA/F3 cells assessed as reduction in cell viability after 48 hrs by Cell titre glo-based luminescence assay	Homo sapiens	35	ALA3774350	cell-based format	Scientific Literature
14.	ALA3778241	B	Inhibition of KDR (unknown origin) expressed in mouse BA/F3 cells assessed as reduction in cell viability after 48 hrs by Cell titre glo-based luminescence assay	Homo sapiens	35	ALA3774350	cell-based format	Scientific Literature
15.	ALA3776063	B	Selectivity ratio of IC50 for KDR inhibition (unknown origin) expressed in mouse BA/F3 cells to IC50 for KIF5B/RET inhibition (unknown origin) expressed in mouse BA/F3 cells	Homo sapiens	35	ALA3774350	cell-based format	Scientific Literature
16.	ALA3776064	A	Intrinsic clearance in iv dosed CD1 mouse assessed per 10'6 cells by LC-MS/MS analysis	Mus musculus	11	ALA3774350	organism-based format	Scientific Literature
17.	ALA3776065	A	Cytotoxicity in mouse BA/F3 cells after 48 hrs by Cell titre glo-based luminescence assay	Mus musculus	11	ALA3774350	cell-based format	Scientific Literature